Cargando…
Mucosal leishmaniasis: epidemiological and clinical aspects
Leishmaniasis has been documented in several countries, with an estimated prevalence of 12 million people and an incidence at around 400,000 new cases per year. Leishmaniasis in the New World is one the major endemic diseases in Brazil and Latin America. Objective: The aim of this study was to add t...
Autores principales: | Miranda Lessa, Marcus, Andrade Lessa, Hélio, Castro, Thomas W.N., Oliveira, Adja, Scherifer, Albert, Machado, Paulo, Carvalho, Edgar M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9450602/ https://www.ncbi.nlm.nih.gov/pubmed/18278231 http://dx.doi.org/10.1016/S1808-8694(15)31181-2 |
Ejemplares similares
-
Assessment of Immune and Clinical Response in Patients with Mucosal Leishmaniasis Treated with Pentavalent Antimony and Pentoxifylline
por: Cincura, Carolina, et al.
Publicado: (2022) -
Geographic Clustering of Leishmaniasis in Northeastern Brazil
por: Schriefer, Albert, et al.
Publicado: (2009) -
High Anti-Leishmania IgG Antibody Levels Are Associated With Severity of Mucosal Leishmaniasis
por: de Lima, Clara Mônica F., et al.
Publicado: (2021) -
Disseminated leishmaniasis: clinical, pathogenic, and therapeutic
aspects
por: Machado, Gustavo Uzêda, et al.
Publicado: (2019) -
Angiomyolipoma of the Nasal Cavity
por: Moreira, Mariana Dória, et al.
Publicado: (2015)